Omicron News and Research

RSS

Formula 1's biggest stars urge all fans to get their COVID-19 vaccine

Formula 1's biggest stars have backed the UK's vaccine rollout and urged all fans to get their jab as soon as possible this winter in a new film out today (Saturday 11 December).

12 Dec 2021

Additional support offered to the social care sector to protect people from Omicron variant

Additional support is being offered to the social care sector as part of a package of new measures to protect people from the spread of the Omicron variant.

12 Dec 2021

Nasal vaccine provides broad-based protection against heterologous respiratory viruses in mice

The emergence of COVID-19 variants such as delta and omicron have sent scientists scrambling to determine whether existing vaccinations and boosters are still effective against new strains of SARS-Cov-2.

11 Dec 2021

UCLA research points the way towards a longer-lasting COVID vaccine

Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have identified rare, naturally occurring T cells that are capable of targeting a protein found in SARS-CoV-2 and a range of other coronaviruses.

11 Dec 2021

Data shows mobility trends during and between the three UK lockdowns

A study by the University of Southampton suggests population movement and social mixing rose sharply following the end of the second COVID-19 UK lockdown and then fell away suddenly a few days before Christmas 2020.

10 Dec 2021

COVID-19 booster program accelerated, 22 million people in the UK have received top-up jabs

More than 22 million people in the UK have now received a COVID-19 top up jab, as the booster programme is accelerated this winter.

10 Dec 2021

Study finds mutational changes in Omicron variant likely increase transmissibility

A new study presented evidence for a large number of mutational changes in the Omicron variant which will likely increase its transmissibility and significantly decrease the neutralization capacity of monoclonal antibodies, leading to a decline in vaccine efficacy.

10 Dec 2021

Mutational landscape of SARS-CoV-2 Omicron variant

New research suggests mutations on the receptor-binding domain of the Omicron variant exert indirect effects that reduce antibody binding to epitopes and promote immune evasion.

10 Dec 2021

Analysis finds substantially more mutations in the omicron SARS-CoV-2 variant

A University of Florida Health researcher has successfully analyzed the many mutations in the omicron variant of the SARS-CoV-2 virus, a crucial step in better understanding the variant's potential threat and ways to combat it.

9 Dec 2021

Assessing the risk of Omicron variant transmission by travelers from South Africa

A new study led by a multinational team of researchers studied the risk of importation of the Omicron variant by travelers from South Africa.

9 Dec 2021

SARS-CoV-2 Omicron variant may bind with ACE2 receptor more efficiently

A new study discusses the effect of the Omicron variant’s mutations on its binding efficiency to the ACE2 receptor.

9 Dec 2021

CDC encourages 16-and-17-year-old adolescents to receive COVID-19 booster shot

Today, CDC is strengthening its booster recommendations and encouraging everyone 16 and older to receive a booster shot. Although we don't have all the answers on the Omicron variant, initial data suggests that COVID-19 boosters help broaden and strengthen the protection against Omicron and other variants.

9 Dec 2021

KHN’s ‘What the Health?’: Much ado about (vaccine) mandates

Even with the new omicron variant of the covid virus spreading in the U.S., Republicans on Capitol Hill are pushing to stop President Joe Biden from requiring workers to either be tested regularly or vaccinated.

9 Dec 2021

Evolution of the SARS-CoV-2 omicron variant

Study shows that the omicron variant shares a common ancestry with the VOI lambda and has evolved mainly because of non-synonymous mutations.

9 Dec 2021

Effect of SARS-CoV-2 variant emergence on efficacy of neutralizing antibodies and vaccines

A review article focuses on the efficacy of neutralizing antibodies and vaccines against the SARS-CoV-2 variants.

9 Dec 2021

Positive results from Phase 3 study of Medicago’s plant-based COVID-19 vaccine candidate announced

Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline today announce positive efficacy and safety results from the global Phase 3 placebo-controlled efficacy study of Medicago’s plant-based COVID-19 vaccine candidate in combination with GSK’s pandemic adjuvant, conducted in over 24,000 subjects, adults 18 years and above, across six countries.

9 Dec 2021

Sugar-binding pockets in N-terminal domain may increase SARS-CoV-2 infectivity

The N-terminal domain has a fold that can bind sugar, and new research led by Jonathan Lees from Oxford Brookes University found the sugar-binding pockets near the N-terminal domain help to increase viral infectivity. Furthermore, the findings show that the SARS-CoV-2 sugar-binding pockets are evolving with added loops observed in the pockets of new variants.

9 Dec 2021

Omicron News and Research

Formula 1's biggest stars urge all fans to get their COVID-19 vaccine

Additional support offered to the social care sector to protect people from Omicron variant

Nasal vaccine provides broad-based protection against heterologous respiratory viruses in mice

UCLA research points the way towards a longer-lasting COVID vaccine

Data shows mobility trends during and between the three UK lockdowns

COVID-19 booster program accelerated, 22 million people in the UK have received top-up jabs

Study finds mutational changes in Omicron variant likely increase transmissibility

Mutational landscape of SARS-CoV-2 Omicron variant

Analysis finds substantially more mutations in the omicron SARS-CoV-2 variant

Assessing the risk of Omicron variant transmission by travelers from South Africa

SARS-CoV-2 Omicron variant may bind with ACE2 receptor more efficiently

CDC encourages 16-and-17-year-old adolescents to receive COVID-19 booster shot

KHN’s ‘What the Health?’: Much ado about (vaccine) mandates

Evolution of the SARS-CoV-2 omicron variant

Effect of SARS-CoV-2 variant emergence on efficacy of neutralizing antibodies and vaccines

Positive results from Phase 3 study of Medicago’s plant-based COVID-19 vaccine candidate announced

Sugar-binding pockets in N-terminal domain may increase SARS-CoV-2 infectivity

Omicron binds to ACE2 with high affinity, enhancing its transmissibility and infectivity

Researchers identify a molecular culprit for COVID-19's seasonal nature

AlphaFold AI predicts SARS-CoV-2 omicron variant might not evade antibody neutralization

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News